About RS Oncology
RS Oncology is currently developing novel therapies to modulate mitochondrial pathways that drive diseases of oxidative stress, focusing initially on cancer.
RS Oncology is currently developing novel therapies to modulate mitochondrial pathways that drive diseases of oxidative stress, focusing initially on cancer.